U.K. weighs drug rationing; Applying Digital; FDA slaps Florida
Jul 20, 2020
U.K. weighs drug rationing as NHS England’s budget tightens: report Patients in the U.K. face yet another barrier to access as a tough budget situation has forced the...
Read More
FDA accepts; Keytruda takes lead; M Pharmaceutical develops; Merck Deploys Palantir
Jun 16, 2020
US FDA accepts Mylan’s BLA for proposed trastuzumab product Biocon and Mylan have announced acceptance of the latter’s biologics licence application (BLA) by the US Foo...
Read More
Sanofi, Regeneron one step closer; Pharma’s deal; J&J and Actelion deal
Jun 16, 2020
Greek prosecutors raid Novartis offices, disclose wide-ranging probe into bribery allegations Greek officials announced that they are investigating Novartis for bribery in ...
Read MoreSanofi sues Novo; Allergan gets help; Actelion snubs; Impax CEO Wilkinson out
Jun 16, 2020
Sanofi sues Novo over ‘misleading’ Tresiba marketing materials Sanofi has sued Novo over the Danish drugmaker’s marketing materials for Tresiba, alleging that...
Read MorePfizer uses; FDA approves; EMA approves; Mylan launches
Jul 20, 2020
For Inflectra launch, Pfizer uses ‘hybrid model’ to home in on HCPs Pfizer hit the market with Inflectra, a biosimilar of Johnson & Johnson’s Remicade...
Read MoreCDC study reveals; Jevtana receives yes; Herantis secures; Immuno-oncology is not cost-effective
Jun 16, 2020
CDC study reveals Zika virus replicates in foetal brain and placentas Study conducted by the US Centers for Disease Control and Prevention (CDC) has revealed that the Zika ...
Read MoreGlaxo replaces ViiV; Lilly nets; AstraZeneca shuffles off; Gazyva aims to beat
Jun 16, 2020
Glaxo replaces ViiV Healthcare chief as executive shuffle continues The executive exodus at GlaxoSmithKline is continuing—and so is the rise of women to the company’s t...
Read More
EC grants; Pfizer cuts; 27 medicines sold; Keytruda nabs
Jul 20, 2020
EC grants marketing authorisation for Takeda’s Ninlaro capsules The European Commission (EC) has granted conditional marketing authorisation for Takeda Pharmaceutical’s...
Read MoreNovartis Buys; FDA approves; Mayne Pharma Launches; Oxford Genetics Receives Grant
Jun 16, 2020
Novartis Buys Blood Disease Drug Maker for $665mn Novartis has acquired Selexys Pharmaceuticals, a drug maker specializing in development of therapeutics in certain hematol...
Read MoreAurobindo’s net profit; LLS selects; Eli Lilly secures; DNA vaccine against Zika
Jun 15, 2020
Aurobindo Pharma Q2 net profit up 33.53% to Rs. 606 cr Aurobindo Pharma reported 33.53 per cent rise in consolidated net profit to Rs 605.64 crore for the quarter ending Se...
Read More
Fresenius Kabi introduced Bivalirudin; Envigo Launches; Mylan’s MAA accepted; Pricing hit pharma
Jun 15, 2020
Fresenius Kabi introduced Bivalirudin for Injection Fresenius Kabi announced that it has introduced Bivalirudin for Injection in the United States, which is an anticoagulan...
Read MoreSun Pharma Announces Launch; OptiNose files; Opiant obtains rights; Swissmedic approves
Jun 15, 2020
Sun Pharma Announces US Launch of Authorized Generics for Benicar, Benicar HCT, Azor and Tribenzor Sun Pharmaceutical Industries Ltd announced that its wholly owned subsidi...
Read MoreBoston Biomedical starts phase III; Martindale receives approval; Merck snagged yes; Nanotechnology to improve HIV
Jun 25, 2020
Boston Biomedical starts phase III study of Napabucasin Boston Biomedical, an industry leader in the development of novel compounds designed to target cancer stemness pathw...
Read More
Merck launches Biosimilars, ABITEC announces extension, First human clinical trial, FDA awards 2grants, Corden Pharma Expands, Juniper Pharma Services Offers
Jun 15, 2020
Merck launches Biosimilars Clarified, a new online educational resource about biosimilar medicines for patients and the healthcare community Merck has announced the launch ...
Read MoreFDA Approves STELARA; Novartis announces AMG 334; AbbVie’s HCV Regimen; PaizaBio Gains CFDA Approval; WuXi Biologics completes construction
Jun 17, 2020
FDA Approves Janssen’s STELARA for the Treatment of Adults With Moderately to Severely Active Crohn’s Disease Janssen Biotech Inc. received approval from the U.S. F...
Read More
